What this is about

Commercial acceleration means identifying the true bottlenecks in the growth system and addressing them decisively: pipeline quality, conversion, pricing, key account logic, distributor performance, market access interfaces and daily steering. In MedTech and Life Sciences, execution must remain compatible with clinical reality, evidence logic and regulatory requirements.

I combine strategic clarity with operational delivery: few high-impact levers—well governed, consistently executed and sustainably anchored.

Typical engagement triggers

• Market penetration below plan: pipeline exists, conversion is weak
• Forecast reliability issues: missing definitions, no cadence, low transparency
• Go-to-market model needs adjustment (channels, roles, territories, incentives)
• Distributor performance insufficient or governance missing
• Pricing/mix pressure: value storytelling, reimbursement, conditions, margin
• Internationalisation: new markets, launches or scale-up phases

My contribution: outcomes & deliverables

• Commercial diagnosis: identify constraints in pipeline, conversion and steering.
• Go-to-market clarity: sharpen segments, value proposition, channel and role model.
• Sales system: stage definitions, cadence, reviews and KPI steering routines.
• Key accounts: prioritisation, account plans and stakeholder management.
• Pricing & value: improve pricing logic, governance, conditions and execution.
• Scale & transfer: anchor structures, enable teams and ensure handover.

Approach: effective from day one

1. Orientation & clarity: align objectives, scope, stakeholders and risks.
2. Focus & prioritisation: define high-impact levers and assign ownership.
3. Execution & governance: establish cadence, KPIs and consistent follow-through.
4. Stabilisation: strengthen leadership routines, team collaboration and accountability.
5. Transfer: anchor impact and ensure sustainability beyond the mandate.

More details

First days in the mandate   S-I-G model

FAQ

How fast are first commercial effects realistic?
Typically within weeks: improved pipeline transparency, cadence, prioritisation and initial implemented measures. Sustainable scaling requires anchoring the system.

How is this different from sales training or consulting?
I take operational responsibility for steering and execution: priorities, governance, ownership and follow-through—until impact is measurable in performance indicators.

Is this suitable for international organisations?
Yes—especially where markets are heterogeneous and a robust commercial steering model is needed to stabilise and scale performance across regions.

Further reading

For practical examples, concise insights and case-based materials, please visit the Resources section.

Open resources

Next step

If commercial execution needs acceleration and reliable steering, we can clarify in a short briefing whether and how an interim assignment creates impact.

Schedule an introductory call   Approach: From entry to impact